Review the following diagnostic laboratory profiles of patients presenting with cushingoid features (such as central obesity, proximal muscle weakness, and abdominal striae). Match each laboratory and testing profile with its most appropriate underlying pathophysiologic etiology.
- Elevated 24-hour urine free cortisol; suppressed plasma ACTH levelUnilateral adrenal adenoma
- Elevated 24-hour urine free cortisol; elevated plasma ACTH level; serum cortisol suppresses by >50% following a high-dose dexamethasone testPituitary corticotroph adenoma (Cushing disease)
- Elevated 24-hour urine free cortisol; elevated plasma ACTH level; no significant suppression of serum cortisol following a high-dose dexamethasone testEctopic ACTH-secreting paraneoplastic syndrome
- Low 24-hour urine free cortisol; suppressed plasma ACTH level; low morning serum cortisol levelExogenous systemic glucocorticoid use
Cevap
Profile 1 matches Adrenal adenoma. Profile 2 matches Pituitary adenoma. Profile 3 matches Ectopic ACTH secretion. Profile 4 matches Exogenous glucocorticoid use.
The standard diagnostic approach to Cushing syndrome requires step-wise biochemical evaluation. Once hypercortisolism is confirmed (via 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression), plasma ACTH is measured. Suppressed ACTH (<5 pg/mL) indicates ACTH-independent disease (e.g., adrenal adenoma). If a patient has suppressed ACTH, low urine cortisol, and cushingoid features, it is diagnostic of exogenous corticosteroid use. Conversely, an elevated ACTH level indicates an ACTH-dependent state. High-dose dexamethasone (8 mg) is then utilized: pituitary adenomas will suppress their ACTH secretion (decreasing cortisol by >50%), whereas ectopic ACTH-producing tumors will not suppress.
Adım Adım Çözüm
Anahtar Kavram
The diagnostic algorithm for Cushing syndrome (hypercortisolism) utilizes ACTH levels to determine dependency, followed by high-dose dexamethasone suppression to localize the source of ACTH.